Pfizer Manufacturing Belgium SA

4,020.8 FTE

Pfizer Manufacturing Belgium reported revenue of €1.02bn for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 02 Jun 2026), with 4,020.8 full-time equivalents.

By total assets for 2025, Pfizer Manufacturing Belgium ranks among the 5 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0400.778.165 · VAT BE0400778165
2870 Puurs-Sint-Amands
active in Manufacture of medicaments (NACE 21201)
operating since 09 Sep 1960 (≈ 66 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Pfizer Manufacturing Belgium shows with a free account.

See the score
Profile
SA Large · 4,020.8 FTE since 1960
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€1.02bn
Net result€101.8m
Equity€1.89bn
Cash€5.20m
EBITDA€250.1m
Total assets€2.46bn
Headcount (avg FTE)4,020.8
The line marks its sector median: 47.2% (76 companies).

Change 2022 → 2025: Revenue -5 % Equity +25 % Total assets +2 % Headcount (avg FTE) 0 %

Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.

The full file covers 11 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Pfizer Manufacturing Belgium's annual accounts

20252024202320222021
Revenue€1.02bn
Net result€101.8m
Equity€1.89bn
Cash€5.20m
EBITDA€250.1m
Total assets€2.46bn

Filed annual accounts

  • Year ended 30 Nov 2025filed on 02 Jun 2026
  • Year ended 30 Nov 2024filed on 26 May 2025
  • Year ended 30 Nov 2023filed on 27 May 2024
  • Year ended 30 Nov 2022filed on 30 May 2023
  • Year ended 30 Nov 2021filed on 03 Jun 2022

Pfizer Manufacturing Belgium's financial analysis

Management and control of Pfizer Manufacturing Belgium

4 active director(s) in the register.

Pfizer Manufacturing Belgium's shareholders and holdings →

Pfizer Manufacturing Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0400.778.165
VAT number
BE0400778165
Peppol
Registered · 0208:0400778165 · as of 10 Nov 2026
Legal form
SA
Incorporated
09 Sep 1960
Registered office
2870 Puurs-Sint-Amands
Size
Large · 4,020.8 FTE
Latest accounts
2025 · filed on 02 Jun 2026
Activity
Manufacture of medicaments (NACE 21201)

Pfizer Manufacturing Belgium (SA) has been based in Puurs-Sint-Amands since 1960, active in: manufacture of medicaments. For 2025, it reports revenue of €1.02bn, a net profit of €101.8m and equity of €1.89bn. With 4,020.8 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 76.7%, above the median of its sector (47.2%).

Guide: Checking a Belgian supplier invoice: numbers and IBAN →

Companies similar to Pfizer Manufacturing Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Pfizer Manufacturing Belgium

What is the revenue of Pfizer Manufacturing Belgium?

According to the 2025 annual accounts filed with the NBB, the revenue of Pfizer Manufacturing Belgium amounts to 1,022,656,208 €.

What is the VAT number of Pfizer Manufacturing Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0400778165 for Pfizer Manufacturing Belgium, if the company is VAT-registered. Its company number (CBE) is 0400.778.165.

Where is the registered office of Pfizer Manufacturing Belgium?

According to the CBE register, the registered office of Pfizer Manufacturing Belgium is in 2870 Puurs-Sint-Amands.

What is the equity of Pfizer Manufacturing Belgium?

At the close of the 2025 financial year, the equity of Pfizer Manufacturing Belgium amounts to 1,885,931,745 €, a solvency of 76.7% of total assets.

How many people work at Pfizer Manufacturing Belgium?

4,020.8 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Pfizer Manufacturing Belgium?

The register lists 4 active mandates at Pfizer Manufacturing Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Pfizer Manufacturing Belgium within its sector?

By total assets for 2025, Pfizer Manufacturing Belgium ranks among the 5 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.

Idonis

The full file of Pfizer Manufacturing Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 22 Oct 2026

No credit card, no commitment.

What each plan unlocks →